| Prev Close: | N/A |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 421.00 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 297.00 - 387.30 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 691,733 |
|---|
| Market Cap: | N/A |
|---|
| P/E (ttm): | 0.00 |
|---|
| EPS (ttm): | 0.05 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in .
Key Statistics
| Forward P/E (1 yr): | 0.00 |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Mar-14)
: | 12.12 |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | 1.8 |
|---|
| PEG Ratio (5 yr expected): | 1.91 |
|---|
Business Summary
BTG plc, a specialist healthcare company, engages in developing and commercializing products targeting critical care, cancer, and other disorders. The company markets and sells specialty pharmaceuticals, including CroFab, a snake bite antivenom to...
View More 
2.29%